Clot-Busting drugs tested to prevent deaths from lung clots
NCT ID NCT07374978
Summary
This study tested whether giving clot-busting drugs (thrombolysis) to patients with severe lung clots (pulmonary embolism) could reduce deaths within 30 days. Researchers compared the drugs against standard blood thinners in 100 patients who were at high risk but had low risk of bleeding. They tracked deaths and serious bleeding events for one month to see if the benefits outweighed the risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM SUBACUTE MASSIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University
Cairo, Abbassia, 00202, Egypt
Conditions
Explore the condition pages connected to this study.